Pathophysiology of human visceral obesity: an update - PubMed (original) (raw)
Review
. 2013 Jan;93(1):359-404.
doi: 10.1152/physrev.00033.2011.
Affiliations
- PMID: 23303913
- DOI: 10.1152/physrev.00033.2011
Free article
Review
Pathophysiology of human visceral obesity: an update
André Tchernof et al. Physiol Rev. 2013 Jan.
Free article
Abstract
Excess intra-abdominal adipose tissue accumulation, often termed visceral obesity, is part of a phenotype including dysfunctional subcutaneous adipose tissue expansion and ectopic triglyceride storage closely related to clustering cardiometabolic risk factors. Hypertriglyceridemia; increased free fatty acid availability; adipose tissue release of proinflammatory cytokines; liver insulin resistance and inflammation; increased liver VLDL synthesis and secretion; reduced clearance of triglyceride-rich lipoproteins; presence of small, dense LDL particles; and reduced HDL cholesterol levels are among the many metabolic alterations closely related to this condition. Age, gender, genetics, and ethnicity are broad etiological factors contributing to variation in visceral adipose tissue accumulation. Specific mechanisms responsible for proportionally increased visceral fat storage when facing positive energy balance and weight gain may involve sex hormones, local cortisol production in abdominal adipose tissues, endocannabinoids, growth hormone, and dietary fructose. Physiological characteristics of abdominal adipose tissues such as adipocyte size and number, lipolytic responsiveness, lipid storage capacity, and inflammatory cytokine production are significant correlates and even possible determinants of the increased cardiometabolic risk associated with visceral obesity. Thiazolidinediones, estrogen replacement in postmenopausal women, and testosterone replacement in androgen-deficient men have been shown to favorably modulate body fat distribution and cardiometabolic risk to various degrees. However, some of these therapies must now be considered in the context of their serious side effects. Lifestyle interventions leading to weight loss generally induce preferential mobilization of visceral fat. In clinical practice, measuring waist circumference in addition to the body mass index could be helpful for the identification and management of a subgroup of overweight or obese patients at high cardiometabolic risk.
Similar articles
- The regulation of adipose tissue distribution in humans.
Björntorp P. Björntorp P. Int J Obes Relat Metab Disord. 1996 Apr;20(4):291-302. Int J Obes Relat Metab Disord. 1996. PMID: 8680455 Review. - Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR, Jorge AR, Braulio VB, Arbex AK, Marcadenti A. Wanderley Rocha DR, et al. Curr Diabetes Rev. 2017;13(1):11-18. doi: 10.2174/1573399812666151015115924. Curr Diabetes Rev. 2017. PMID: 26467189 - Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity.
Maeda A, Tamura K, Wakui H, Dejima T, Ohsawa M, Azushima K, Kanaoka T, Uneda K, Matsuda M, Yamashita A, Miyazaki N, Yatsu K, Hirawa N, Toya Y, Umemura S. Maeda A, et al. J Am Heart Assoc. 2013 Jul 31;2(4):e000312. doi: 10.1161/JAHA.113.000312. J Am Heart Assoc. 2013. PMID: 23902639 Free PMC article. - A Common Variant of NGEF Is Associated with Abdominal Visceral Fat in Korean Men.
Kim HJ, Park JH, Lee S, Son HY, Hwang J, Chae J, Yun JM, Kwon H, Kim JI, Cho B. Kim HJ, et al. PLoS One. 2015 Sep 4;10(9):e0137564. doi: 10.1371/journal.pone.0137564. eCollection 2015. PLoS One. 2015. PMID: 26340433 Free PMC article. - Fructose-induced inflammation and increased cortisol: A new mechanism for how sugar induces visceral adiposity.
DiNicolantonio JJ, Mehta V, Onkaramurthy N, O'Keefe JH. DiNicolantonio JJ, et al. Prog Cardiovasc Dis. 2018 May-Jun;61(1):3-9. doi: 10.1016/j.pcad.2017.12.001. Epub 2017 Dec 8. Prog Cardiovasc Dis. 2018. PMID: 29225114 Review.
Cited by
- Association of visceral fat area with early-stage locomotive syndrome across various age groups: a cross-sectional study.
Miyazaki T, Ozato N, Yamaguchi T, Sugiura Y, Kawada H, Katsuragi Y, Osaki N, Mikami T, Ito K, Murashita K, Nakaji S, Tamada Y. Miyazaki T, et al. Sci Rep. 2024 Oct 26;14(1):25498. doi: 10.1038/s41598-024-76478-8. Sci Rep. 2024. PMID: 39462134 Free PMC article. - Diet Quality and Visceral Adiposity among a Multiethnic Population of Young, Middle, and Older Aged Adults.
Panizza CE, Wong MC, Kelly N, Liu YE, Shvetsov YB, Lowe DA, Weiss EJ, Heymsfield SB, Kennedy S, Boushey CJ, Maskarinec G, Shepherd JA. Panizza CE, et al. Curr Dev Nutr. 2020 May 26;4(6):nzaa090. doi: 10.1093/cdn/nzaa090. eCollection 2020 Jun. Curr Dev Nutr. 2020. PMID: 33959689 Free PMC article. - Forkhead box O-1 modulation improves endothelial insulin resistance in human obesity.
Karki S, Farb MG, Ngo DT, Myers S, Puri V, Hamburg NM, Carmine B, Hess DT, Gokce N. Karki S, et al. Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1498-506. doi: 10.1161/ATVBAHA.114.305139. Epub 2015 Apr 23. Arterioscler Thromb Vasc Biol. 2015. PMID: 25908760 Free PMC article. - Regional adiposity and heart failure with preserved ejection fraction.
Rao VN, Fudim M, Mentz RJ, Michos ED, Felker GM. Rao VN, et al. Eur J Heart Fail. 2020 Sep;22(9):1540-1550. doi: 10.1002/ejhf.1956. Epub 2020 Aug 5. Eur J Heart Fail. 2020. PMID: 32619081 Free PMC article. Review. - The Association Between Visceral Obesity and Postoperative Outcomes in Elderly Patients With Colorectal Cancer.
Dong Q, Song H, Chen W, Wang W, Ruan X, Xie T, Huang D, Chen X, Xing C. Dong Q, et al. Front Surg. 2022 Jun 6;9:827481. doi: 10.3389/fsurg.2022.827481. eCollection 2022. Front Surg. 2022. PMID: 36034360 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources